Skip to main content

Arcutis Biotherapeutics, Inc.

ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001787306

In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Arcutis Biotherapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
272
+5 vs. Q1 2026
Shares held
131.4M
+936.9K (+0.7%) vs. Q1 2026
Total value
$3.45B
+$372.0M (+12.1%) vs. Q1 2026
New holders
41
95 more added
Sold out
36
100 more reduced

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 272 institutions
Q1 2021: 94 institutionsQ2 2021: 102 institutionsQ3 2021: 103 institutionsQ4 2021: 93 institutionsQ1 2022: 106 institutionsQ2 2022: 115 institutionsQ3 2022: 139 institutionsQ4 2022: 141 institutionsQ1 2023: 144 institutionsQ2 2023: 136 institutionsQ3 2023: 134 institutionsQ4 2023: 133 institutionsQ1 2024: 168 institutionsQ2 2024: 186 institutionsQ3 2024: 188 institutionsQ4 2024: 208 institutionsQ1 2025: 241 institutionsQ2 2025: 230 institutionsQ3 2025: 239 institutionsQ4 2025: 283 institutionsQ1 2026: 270 institutionsQ2 2026: 272 institutions
Value heldQ2 2026: $3.45B
Q1 2021: $1.35BQ2 2021: $1.24BQ3 2021: $1.09BQ4 2021: $961.8MQ1 2022: $929.8MQ2 2022: $1.05BQ3 2022: $1.13BQ4 2022: $979.6MQ1 2023: $787.6MQ2 2023: $684.0MQ3 2023: $356.7MQ4 2023: $327.1MQ1 2024: $1.24BQ2 2024: $1.18BQ3 2024: $1.20BQ4 2024: $1.79BQ1 2025: $1.97BQ2 2025: $1.78BQ3 2025: $2.37BQ4 2025: $3.75BQ1 2026: $3.12BQ2 2026: $3.45B
Institutions holding ARQT and their total value by quarter
QuarterHoldersValue
Q2 2026272$3.45B
Q1 2026270$3.12B
Q4 2025283$3.75B
Q3 2025239$2.37B
Q2 2025230$1.78B
Q1 2025241$1.97B
Q4 2024208$1.79B
Q3 2024188$1.20B
Q2 2024186$1.18B
Q1 2024168$1.24B
Q4 2023133$327.1M
Q3 2023134$356.7M
Q2 2023136$684.0M
Q1 2023144$787.6M
Q4 2022141$979.6M
Q3 2022139$1.13B
Q2 2022115$1.05B
Q1 2022106$929.8M
Q4 202193$961.8M
Q3 2021103$1.09B
Q2 2021102$1.24B
Q1 202194$1.35B

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q1 2026.

Institutions holding ARQT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
SMA Capital LLC0$00.00%−239−100.0%Sold out
Sound Income Strategies, LLC0$00.00%−186−100.0%Sold out
MAI Capital Management0$00.00%−152−100.0%Sold out
Root Financial Partners, LLC0$00.00%−61−100.0%Sold out
Advisory Services Network, LLC0$00.00%−19−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−7−100.0%Sold out
Twin Peaks Wealth Advisors, LLC0$00.00%−7−100.0%Sold out
Basecamp Wealth Advisors LLC0$00.00%−4−100.0%Sold out
Janus Henderson Group PLC––––Not filed
CWM, LLC––––Not filed
Sunbelt Securities, Inc.––––Not filed